close image of firbro blasts

Welcome

The Center for Cell Reprogramming pursues and promotes research on stem-like cells, emphasizing conditionally reprogrammed cells. We proudly work with GUMC to integrate stem cell biology into the existing basic, translational and clinical programs.
A Welcome from Our Director

Welcome to the Center for Cell Reprogramming

Medical Dental Building, Georgetown University

The Center for Cell Reprogramming pursues and promotes research on stem-like cells, with an emphasis on conditionally reprogrammed cells, adult stem cells and their relevant biological/medical applications. We serve as a nidus for faculty recruitment, for internal and external research collaborations, and for facilitating funding from the National Institutes of Health, Department of Defense, pharmaceutical companies and foundations

Dr. Richard Schlegel in his office

Dr. Richard Schlegel

With over 25 years of experience at GUMC Dr. Richard Schlegel has helped connect immunology and pathology research as well as pioneer technology on HPV and recently cell biology, which has resulted in what we now know as conditional reprogramming.

More
Publication from the Schlegel laboratory

Publication from the Schlegel laboratory

The Schlegel laboratory has produced some fascinating articles over the past few years. See what the latest publications are from current and past faculty and lab members!

More
2016 Center for Cell Reprogramming team of faculty, researchers and staff

2016 Center for Cell Reprogramming team of faculty, researchers and staff

Our laboratory is filled with unique and diverse individuals who aim for excellence in all their research. Find out who we are!

More
Data from the Schlegel laboratory

Data from the Schlegel laboratory

If you are a researcher and interested in submitting a request for tissue cultures or using our live cell imaging click here to go to our Forms page.

More
Doctor's Speak Out   Featuring: Dr. Richard Schlegel

Doctor’s Speak Out Featuring: Dr. Richard Schlegel

Dr. Richard Schlegel discussed his work at the latest session. Read Georgetown University Medical Center’s article on the event!

More

In the Spotlight

two doctors conferring

A Bed of Mouse Cells Helps Human Cells Thrive In the Lab

January 7th, 2015

Dr. Richard Schlegel speaks with Richard Harris, NPR, to talk about using his groundbreaking techniques in cell reprogramming to test artemisinin-a drug commonly used to treat malaria-to kill cervical cancer cells.

Dr. Richard Schlegel

Medical Center Researchers Named National Academy of Inventors Fellows

December 16th, 2014

Dr. Richard Schlegel has been named one of the 2014 Fellows of the National Academy of Inventors (NAI) for his groundbreaking discovery of the HPV vaccine. Read how the technology he co-developed has helped drop HPV infections by 56 percent in the US, according to the American Cancer Society.

Dr. Richard Schlegel in his office (black/white photo)

Researchers Test Cancer Treatments on Patients’ Own Cells

November 13th, 2014

Dr. Richard Schlegel is quoted in The Boston Globe’s news story which highlights research recently published by Dr. Jeff Engelman, Director of Thoracic Oncology at Massachusetts General Hospital. Dr. Engelman co-led a group of physicians and researchers towards new steps in personalized cancer treament using technology invented by Dr. Schlegel.

Upcoming Events

There are no upcoming events.